Spruce Biosciences, Inc. Common Stock (SPRB) is a publicly traded the market company. As of May 21, 2026, SPRB trades at $51.50 with a market cap of $138.92M and a P/E ratio of -1.02. SPRB moved +7.09% today. Year to date, SPRB is -37.27%; over the trailing twelve months it is +429.99%. Its 52-week range spans $4.28 to $240.00. Analyst consensus is strong buy with an average price target of $178.60. Rallies surfaces SPRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Spruce Biosciences, Inc. Common Stock (SPRB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SPRB moved +7.09% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $51.50 |
| Market Cap | $138.92M |
| P/E Ratio | -1.02 |
| EPS | $-50.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $240.00 |
| 52-Week Low | $4.28 |
| Volume | 58.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-38.97M |
| Gross Margin | 0.00% |
5 analysts cover SPRB: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $178.60.